Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Diabetes Docs Wary of MannKind's Afrezza Insulin, Analyst Survey Finds
Diabetes Docs Wary of MannKind's Afrezza Insulin, Analyst Survey Finds
Diabetes Docs Wary of MannKind's Afrezza Insulin, Analyst Survey Finds
Submitted by
admin
on June 9, 2015 - 9:51am
Source:
TheStreet.com
News Tags:
physicians
diabetes
MannKind
insulin
Afrezza
Headline:
Diabetes Docs Wary of MannKind's Afrezza Insulin, Analyst Survey Finds
Do Not Allow Advertisers to Use My Personal information
